Related Experiment Videos
Expression of antisense epidermal growth factor receptor RNA downmodulates the malignant behavior of human colon
S Chakrabarty1, S Rajagopal, S Huang
1Division of Laboratory Medicine, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Abstract:
Human colon cancer (Moser) cells produce and secrete epidermal growth factor (EGF) and respond to EGF via an autocrine/paracrine mode through the cell surface EGF receptor (EGFR). In this report we show that EGF promotes the malignant behavior of the Moser cells in vitro in terms of growth in soft agarose and invasion of Matrigel-coated porous membranes. Expressing antisense EGFR RNA in the Moser cells (through transfection with an inducible antisense EGFR expression vector) downmodulated the expression of cell surface EGFR and EGFR mRNA with a concurrent inhibition of growth in soft agarose and invasion of Matrigel-coated membranes. In addition, the ability of exogenously applied EGF in promoting the malignant behavior of these cells was circumvented. We conclude that antisense EGFR RNA was a potent agent in circumventing the in vitro malignant properties of the Moser cells.
Insights
Antisense epidermal growth factor receptor (EGFR) RNA inhibited malignant behaviors in human colon cancer cells. This approach effectively reduced cell growth and invasion, offering a potential therapeutic strategy for colon cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Human colon cancer (Moser) cells exhibit autocrine/paracrine signaling via epidermal growth factor (EGF) and its receptor (EGFR).
- EGF stimulation promotes malignant phenotypes in Moser cells, including enhanced growth and invasion.
Purpose of the Study:
- To investigate the role of epidermal growth factor receptor (EGFR) in colon cancer cell malignancy.
- To evaluate the efficacy of antisense EGFR RNA in inhibiting malignant behaviors of human colon cancer cells.
Main Methods:
- Transfection of Moser cells with an inducible antisense EGFR expression vector.
- Assessment of cell surface EGFR and EGFR mRNA expression levels.
- Evaluation of in vitro malignant behaviors: soft agarose colony formation and Matrigel invasion assays.
Main Results:
- Antisense EGFR RNA significantly downmodulated cell surface EGFR and EGFR mRNA expression.
- Inhibition of EGFR expression led to concurrent suppression of soft agarose growth and Matrigel invasion.
- The pro-malignant effects of exogenous EGF were circumvented by antisense EGFR RNA expression.
Conclusions:
- Antisense EGFR RNA is a potent agent for circumventing in vitro malignant properties of colon cancer cells.
- Targeting EGFR with antisense RNA demonstrates therapeutic potential for colon cancer treatment.